Retension Pharmaceuticals, Inc. RTSN
11.79 USD +0.49 (+4.34%)
At closeNov 3, 2026, 4:00 PM EST
11.79 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
11.07 Day range 12.25
9.66 52-week range 18.64
- YTD
- +11.97%
- 1 year
- +11.97%
News
benzinga.com Oppenheimer Initiates Coverage On Retension Pharmaceuticals with Outperform Rating, Announces Price Target of $50 Oppenheimer analyst Jay Olson initiates coverage on Retension Pharmaceuticals (NASDAQ:RTSN) with a Outperform rating and announces Price Target of $50.
benzinga.com Guggenheim Initiates Coverage On Retension Pharmaceuticals with Buy Rating, Announces Price Target of $55 Guggenheim analyst Seamus Fernandez initiates coverage on Retension Pharmaceuticals (NASDAQ:RTSN) with a Buy rating and announces Price Target of $55.
globenewswire.com Retension Pharmaceuticals Announces Pricing of Initial Public Offering FALLS CHURCH, Va., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Retension Pharmaceuticals, Inc. (Nasdaq: RTSN) (“Retension” or the “Company”), a clinical-stage biopharmaceutical company focused on developing…